4D Molecular Therapeutics, Inc.FDMTNASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank100
3Y CAGR+6.6%
5Y CAGR+12.9%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+6.6%/yr
vs +44.6%/yr prior
5Y CAGR
+12.9%/yr
Recent deceleration
Acceleration
-38.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.8x
Solid growth
Streak
1 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $97.17M | - |
| 2024 | $0.00 | -100.0% |
| 2023 | $97.10M | +21.0% |
| 2022 | $80.25M | +30.8% |
| 2021 | $61.36M | +15.7% |
| 2020 | $53.04M | +37.0% |
| 2019 | $38.72M | +110.9% |
| 2018 | $18.36M | +35.3% |
| 2017 | $13.57M | - |